<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00518596</url>
  </required_header>
  <id_info>
    <org_study_id>GN 07 Phase II</org_study_id>
    <secondary_id>U01HD040574</secondary_id>
    <secondary_id>R01HD053719</secondary_id>
    <nct_id>NCT00518596</nct_id>
  </id_info>
  <brief_title>Prevention of Infection in Indian Neonates - Phase II Probiotics Study</brief_title>
  <official_title>Prevention of Infection in Indian Neonates - Phase II Probiotics Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NICHD Global Network for Women's and Children's Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Global Network for Women's and Children's Health Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>John E. Fogarty International Center (FIC)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Dental and Craniofacial Research (NIDCR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>RTI International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TN Medical College, Mumbai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Health and Family Welfare, Orissa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SCB Medical College, Cuttack</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Capital Hospital, Bhubaneswar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ispat General Hospital, Rourkela</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kalinga Hospital, Bhubaneswar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NICHD Global Network for Women's and Children's Health</source>
  <brief_summary>
    <textblock>
      India, with one of the world's largest populations, continues to struggle with extremely high
      infant and neonatal mortality rates. Neonatal infection (sepsis) now accounts for 50 percent
      of deaths among community-born (and 20 percent of mortality among hospital-born) infants.
      This study is the first phase of a multi-phase project investigating interventions to prevent
      neonatal infection in India.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase II is a hospital based intervention (n = 297 infants) measuring the colonizing ability,
      safety, and tolerance of a probiotic supplement, Lactobacillus plantarum in the neonatal gut.
      Newborn infants ≥ 35 weeks of gestation will be randomized to receive either L. plantarum
      preparations (containing 109 organisms) or placebo preparations orally once a day for the
      first 7 days of life. The final stage of the project will be a community-based randomized
      double-blind placebo-controlled trial of L. plantarum enrolling over 8,000 newborns to
      examine the efficacy of probiotic supplementation in reducing neonatal infection in Indian
      neonates.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">August 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colonizing ability of L. plantarum in Indian neonates after 5-7 days of administration.</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical safety (including sepsis and death) and tolerance of a daily administration of oral L. plantarum probiotic supplement when used in healthy full-term neonates.</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in stool microfloral patterns with 5-7 day administration of L. plantarum supplement.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feasibility of the future community study (consent and retention rates, completeness of stool sampling, ability to complete the study in the home for infants discharged early).</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">284</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Probiotic Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Newborn infants' ≥ 35 weeks of gestation and ≥1800g, given L. plantarum preparations orally once a day starting on day 1, 2, or 3 of life and continuing for seven days thereafter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Newborn infants' ≥ 35 weeks of gestation and ≥1800g, receiving placebo preparations (a control solution of sterile 2.0 cc 5% dextrose-saline)orally once a day starting on day 1, 2, or 3 of life and continuing for seven days thereafter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic supplementation (Lactobacillus plantarum)</intervention_name>
    <description>GastroPlan capsules from a single lot will be used. The intervention consists of L. plantarum reconstituted in sterile 2.0 cc of 5% dextrose-saline, administered orally using an opaque-amber syringe.</description>
    <arm_group_label>Probiotic Arm</arm_group_label>
    <arm_group_label>Control Arm</arm_group_label>
    <other_name>Gastroplan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants ≥ 35 weeks and ≥1800g born in the hospital

          -  Infants &gt; 12 hours and &lt; 72 hours of age at enrollment

          -  Infants likely to be hospitalized for 5-7 days without antibiotic treatment

          -  Informed consent by one parent or guardian

          -  Infants begun breastfeeding

        Exclusion Criteria:

          -  Antibiotic therapy prior to enrollment

          -  Evidence or suspicion of clinical sepsis before randomization

          -  Inability (as determined by the physician) to tolerate oral feeding of study
             supplement

          -  Presence of major congenital anomalies

          -  Infant's home is &gt;30km away from hospital A major congenital anomaly is defined as any
             malformation that is felt to be life-threatening or that requires surgical
             intervention. If the medical officer is uncertain whether an anomaly is
             life-threatening, he/she should not enroll the infant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>72 Hours</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pinaki Panigrahi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Capital Hospital</name>
      <address>
        <city>Bhubaneswar</city>
        <state>Orissa</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalinga Hospital</name>
      <address>
        <city>Bhubaneswar</city>
        <state>Orissa</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ispat General Hospital</name>
      <address>
        <city>Rourkela</city>
        <state>Orissa</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <link>
    <url>http://gn.rti.org</url>
    <description>Global Network for Women's and Children's Health Research</description>
  </link>
  <link>
    <url>http://www.rti.org</url>
    <description>RTI International</description>
  </link>
  <link>
    <url>https://projectreporter.nih.gov/project_info_description.cfm?aid=6332410&amp;icde=33151915&amp;ddparam=&amp;ddvalue=&amp;ddsub=&amp;cr=7&amp;csb=default&amp;cs=ASC&amp;pball=</url>
    <description>RePORTer link to abstract-U0-1 HD 40574 (Prevention of Infection in Indian Neonates)</description>
  </link>
  <link>
    <url>https://projectreporter.nih.gov/project_info_description.cfm?aid=7260679&amp;icde=33151915&amp;ddparam=&amp;ddvalue=&amp;ddsub=&amp;cr=12&amp;csb=default&amp;cs=ASC&amp;pball</url>
    <description>RePORTer link to abstract R0-1 HD 53719 (Prevention of Neonatal Infection in the Indian Community Setting Using Probiotics)</description>
  </link>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2007</study_first_submitted>
  <study_first_submitted_qc>August 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2007</study_first_posted>
  <last_update_submitted>June 13, 2017</last_update_submitted>
  <last_update_submitted_qc>June 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neonatal</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Global Network</keyword>
  <keyword>Probiotics</keyword>
  <keyword>India</keyword>
  <keyword>International</keyword>
  <keyword>Maternal and child health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

